Merck’s Drug Approved for EU Market $MRK $XHS

European regulators have approved¬†Merck & Co Inc’s immune system-boosting cancer drug Keytruda for marketing in Europe.

The Drug;Pembrolizumab was also approved by EMA on Friday.

View the full release here.